m.p. bio science limited Company Information
Company Number
06371250
Next Accounts
Sep 2025
Shareholders
koko corporation ltd
Group Structure
View All
Industry
Manufacture of other food products n.e.c.
Registered Address
3a/b harrison court, hilton, derby, DE65 5UR
Website
www.mpbioscience.comm.p. bio science limited Estimated Valuation
Pomanda estimates the enterprise value of M.P. BIO SCIENCE LIMITED at £1.2m based on a Turnover of £2m and 0.57x industry multiple (adjusted for size and gross margin).
m.p. bio science limited Estimated Valuation
Pomanda estimates the enterprise value of M.P. BIO SCIENCE LIMITED at £660.4k based on an EBITDA of £165.2k and a 4x industry multiple (adjusted for size and gross margin).
m.p. bio science limited Estimated Valuation
Pomanda estimates the enterprise value of M.P. BIO SCIENCE LIMITED at £2.8m based on Net Assets of £1.5m and 1.94x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
M.p. Bio Science Limited Overview
M.p. Bio Science Limited is a live company located in derby, DE65 5UR with a Companies House number of 06371250. It operates in the manufacture of other food products n.e.c. sector, SIC Code 10890. Founded in September 2007, it's largest shareholder is koko corporation ltd with a 100% stake. M.p. Bio Science Limited is a established, small sized company, Pomanda has estimated its turnover at £2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
M.p. Bio Science Limited Health Check
Pomanda's financial health check has awarded M.P. Bio Science Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
4 Weak
Size
annual sales of £2m, make it smaller than the average company (£24.1m)
- M.p. Bio Science Limited
£24.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -9%, show it is growing at a slower rate (7.7%)
- M.p. Bio Science Limited
7.7% - Industry AVG
Production
with a gross margin of 24.9%, this company has a comparable cost of product (24.9%)
- M.p. Bio Science Limited
24.9% - Industry AVG
Profitability
an operating margin of 8.1% make it more profitable than the average company (3.6%)
- M.p. Bio Science Limited
3.6% - Industry AVG
Employees
with 2 employees, this is below the industry average (112)
2 - M.p. Bio Science Limited
112 - Industry AVG
Pay Structure
on an average salary of £39.2k, the company has an equivalent pay structure (£39.2k)
- M.p. Bio Science Limited
£39.2k - Industry AVG
Efficiency
resulting in sales per employee of £1m, this is more efficient (£235.4k)
- M.p. Bio Science Limited
£235.4k - Industry AVG
Debtor Days
it gets paid by customers after 12 days, this is earlier than average (48 days)
- M.p. Bio Science Limited
48 days - Industry AVG
Creditor Days
its suppliers are paid after 70 days, this is slower than average (44 days)
- M.p. Bio Science Limited
44 days - Industry AVG
Stock Days
it holds stock equivalent to 285 days, this is more than average (49 days)
- M.p. Bio Science Limited
49 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 15 weeks, this is more cash available to meet short term requirements (7 weeks)
15 weeks - M.p. Bio Science Limited
7 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24.7%, this is a lower level of debt than the average (56.3%)
24.7% - M.p. Bio Science Limited
56.3% - Industry AVG
M.P. BIO SCIENCE LIMITED financials
M.P. Bio Science Limited's latest turnover from December 2023 is estimated at £2 million and the company has net assets of £1.5 million. According to their latest financial statements, M.P. Bio Science Limited has 2 employees and maintains cash reserves of £138.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 2 | 23 | 27 | 12 | 12 | 14 | 14 | 19 | 18 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 415,375 | 398,614 | 125,278 | 154,479 | 187,759 | 212,629 | 247,858 | 255,339 | 279,700 | 280,679 | 281,629 | 922,915 | 828,624 | 745,351 | 760,999 |
Intangible Assets | 1,500 | 2,250 | 3,000 | 3,750 | 4,500 | 5,250 | 6,000 | 6,750 | 7,500 | 0 | 0 | 0 | 0 | 683 | 219 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 416,875 | 400,864 | 128,278 | 158,229 | 192,259 | 217,879 | 253,858 | 262,089 | 287,200 | 280,679 | 281,629 | 922,915 | 828,624 | 746,034 | 761,269 |
Stock & work in progress | 1,189,130 | 1,138,381 | 1,345,970 | 1,075,806 | 797,345 | 706,298 | 608,866 | 503,585 | 698,261 | 789,650 | 680,972 | 577,074 | 429,097 | 351,042 | 294,562 |
Trade Debtors | 66,754 | 277,103 | 248,273 | 259,820 | 197,936 | 272,509 | 473,138 | 256,065 | 407,651 | 442,210 | 500,054 | 386,901 | 383,481 | 352,586 | 373,903 |
Group Debtors | 40,139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 77,757 | 65,975 | 49,687 | 78,326 | 68,835 | 39,012 | 33,832 | 33,411 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 138,318 | 921 | 9,445 | 837 | 2,831 | 3,848 | 1,476 | 7,793 | 25,311 | 467 | 142,521 | 312,451 | 135,865 | 70,498 | 23,048 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,512,098 | 1,482,380 | 1,653,375 | 1,414,789 | 1,066,947 | 1,021,667 | 1,117,312 | 800,854 | 1,131,223 | 1,232,327 | 1,323,547 | 1,276,426 | 948,443 | 774,126 | 691,513 |
total assets | 1,928,973 | 1,883,244 | 1,781,653 | 1,573,018 | 1,259,206 | 1,239,546 | 1,371,170 | 1,062,943 | 1,418,423 | 1,513,006 | 1,605,176 | 2,199,341 | 1,777,067 | 1,520,160 | 1,452,782 |
Bank overdraft | 0 | 46,038 | 14,762 | 161,890 | 54,165 | 49,634 | 118,591 | 31,067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 294,713 | 257,656 | 408,830 | 138,545 | 218,934 | 243,649 | 225,307 | 150,566 | 457,977 | 566,081 | 676,766 | 764,619 | 526,628 | 403,510 | 423,241 |
Group/Directors Accounts | 0 | 82,152 | 46,004 | 177,826 | 28,563 | 113,937 | 112,157 | 89,699 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 164,779 | 154,428 | 80,545 | 88,166 | 287,326 | 19,579 | 67,224 | 77,370 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 459,492 | 540,274 | 550,141 | 566,427 | 588,988 | 426,799 | 523,279 | 348,702 | 457,977 | 566,081 | 676,766 | 764,619 | 526,628 | 403,510 | 423,241 |
loans | 0 | 0 | 250,000 | 99,523 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,083 | 10,554 | 4,307 | 371,126 | 425,046 | 453,712 | 479,849 |
provisions | 16,570 | 14,195 | 23,803 | 26,061 | 36,814 | 41,123 | 41,123 | 47,164 | 47,164 | 47,437 | 45,305 | 23,768 | 22,379 | 19,319 | 17,120 |
total long term liabilities | 16,570 | 14,195 | 273,803 | 125,584 | 36,814 | 41,123 | 41,123 | 47,164 | 61,247 | 57,991 | 49,612 | 394,894 | 447,425 | 473,031 | 496,969 |
total liabilities | 476,062 | 554,469 | 823,944 | 692,011 | 625,802 | 467,922 | 564,402 | 395,866 | 519,224 | 624,072 | 726,378 | 1,159,513 | 974,053 | 876,541 | 920,210 |
net assets | 1,452,911 | 1,328,775 | 957,709 | 881,007 | 633,404 | 771,624 | 806,768 | 667,077 | 899,199 | 888,934 | 878,798 | 1,039,828 | 803,014 | 643,619 | 532,572 |
total shareholders funds | 1,452,911 | 1,328,775 | 957,709 | 881,007 | 633,404 | 771,624 | 806,768 | 667,077 | 899,199 | 888,934 | 878,798 | 1,039,828 | 803,014 | 643,619 | 532,572 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 46,075 | 35,812 | 35,812 | 38,205 | 45,479 | 42,535 | 44,894 | 41,399 | 27,437 | 33,144 | 30,980 | ||||
Amortisation | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Tax | |||||||||||||||
Stock | 50,749 | -207,589 | 270,164 | 278,461 | 91,047 | 97,432 | -89,395 | -194,676 | -91,389 | 108,678 | 103,898 | 147,977 | 78,055 | 56,480 | 294,562 |
Debtors | -158,428 | 45,118 | -40,186 | 71,375 | -44,750 | -195,449 | 99,319 | -118,175 | -34,559 | -57,844 | 113,153 | 3,420 | 30,895 | -21,317 | 373,903 |
Creditors | 37,057 | -151,174 | 270,285 | -80,389 | -24,715 | 18,342 | -232,670 | -307,411 | -108,104 | -110,685 | -87,853 | 237,991 | 123,118 | -19,731 | 423,241 |
Accruals and Deferred Income | 10,351 | 73,883 | -7,621 | -199,160 | 267,747 | -47,645 | 67,224 | 77,370 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 2,375 | -9,608 | -2,258 | -10,753 | -4,309 | 0 | -6,041 | 0 | -273 | 2,132 | 21,537 | 1,389 | 3,060 | 2,199 | 17,120 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51 | 51 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -82,152 | 36,148 | -131,822 | 149,263 | -85,374 | 1,780 | 112,157 | 89,699 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -250,000 | 150,477 | 99,523 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -14,083 | -14,083 | 3,529 | 6,247 | -366,819 | -53,920 | -28,666 | -26,137 | 479,849 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 137,397 | -8,524 | 8,608 | -1,994 | -1,017 | 2,372 | -23,835 | -17,518 | 24,844 | -142,054 | -169,930 | 176,586 | 65,367 | 47,450 | 23,048 |
overdraft | -46,038 | 31,276 | -147,128 | 107,725 | 4,531 | -68,957 | 118,591 | 31,067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 183,435 | -39,800 | 155,736 | -109,719 | -5,548 | 71,329 | -142,426 | -48,585 | 24,844 | -142,054 | -169,930 | 176,586 | 65,367 | 47,450 | 23,048 |
m.p. bio science limited Credit Report and Business Information
M.p. Bio Science Limited Competitor Analysis
Perform a competitor analysis for m.p. bio science limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in DE65 area or any other competitors across 12 key performance metrics.
m.p. bio science limited Ownership
M.P. BIO SCIENCE LIMITED group structure
M.P. Bio Science Limited has no subsidiary companies.
m.p. bio science limited directors
M.P. Bio Science Limited currently has 3 directors. The longest serving directors include Mr Ross McManus (Sep 2007) and Mrs Remila McManus (Jun 2008).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Ross McManus | 61 years | Sep 2007 | - | Director | |
Mrs Remila McManus | England | 58 years | Jun 2008 | - | Director |
Mr Andrew Southam | England | 63 years | Nov 2020 | - | Director |
P&L
December 2023turnover
2m
-39%
operating profit
164.4k
0%
gross margin
24.9%
-1.42%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.5m
+0.09%
total assets
1.9m
+0.02%
cash
138.3k
+149.18%
net assets
Total assets minus all liabilities
m.p. bio science limited company details
company number
06371250
Type
Private limited with Share Capital
industry
10890 - Manufacture of other food products n.e.c.
incorporation date
September 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
3a/b harrison court, hilton, derby, DE65 5UR
Bank
-
Legal Advisor
-
m.p. bio science limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to m.p. bio science limited.
m.p. bio science limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for M.P. BIO SCIENCE LIMITED. This can take several minutes, an email will notify you when this has completed.
m.p. bio science limited Companies House Filings - See Documents
date | description | view/download |
---|